CLOs on the Move

PURE Gen Holdings

www.livepure.com

 
When it comes to our health, we as a society, have gone off course. Nearly 70% of us are overweight or obese. This makes us prime candidates to acquire preventable chronic diseases, which further reduce our quality of life. Given that chronic diseases...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.livepure.com
  • 7164, Technology Drive
    Frisco, TX USA 75034
  • Phone: 866.535.5888

Executives

Name Title Contact Details

Similar Companies

Siemens Healthcare

Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to meet their current challenges and to excel in their respective environments. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. To help customers succeed in today`s dynamic healthcare marketplace, Siemens Healthineers is championing new business models that maximize opportunity and minimize risk for healthcare providers.

Rodeo Dental and Orthodontics

Rodeo Dental & Orthodontics is transforming the world of dentistry into a bright, fun-filled, high-end experience. How? By combining beautiful smiles, world-class service, and magical patient engagement techniques into memorable experiences that are shared instantly with family and friends!

Endotec Inc

Endotec Inc is a South Orange, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Genetics and IVF Institute

Genetics and IVF Institute is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Genetics and IVF Institute is based in Fairfax, VA. You can find more information on Genetics and IVF Institute at www.givf.com

Oklahoma Medical Research Foundation

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.